PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma.
Karlin
Lionel
L
Department of Hematology, Hôpital Henri Mondor, 94010 Créteil cedex, France.
Itti
Emmanuel
E
Pautas
Cécile
C
Rachid
Mohamed
M
Bories
Dominique
D
Cordonnier
Catherine
C
Maury
Sébastien
S
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D004379:Duodenal Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000235:genetics / Q000601:surgery; D042241:Early Diagnosis; D006801:Humans; D017254:Leukemic Infiltration / Q000188:drug therapy; D008297:Male; D008578:Meninges / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging* / Q000188:drug therapy; D015514:Oncogene Proteins, Fusion / Q000032:analysis / Q000235:genetics; D049268:Positron-Emission Tomography; D012074:Remission Induction; D023981:Sarcoma, Myeloid / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000235:genetics / Q000601:surgery; D014184:Transplantation, Homologous
D014408:Biomarkers, Tumor; C095514:CBFbeta-MYH11 fusion protein; D015514:Oncogene Proteins, Fusion; D003561:Cytarabine